Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

51.000
+1.3602.74%
Volume:37.24M
Turnover:1.87B
Market Cap:211.40B
PE:37.66
High:51.000
Open:49.500
Low:48.620
Close:49.640
52wk High:51.550
52wk Low:28.480
Shares:4.15B
HK Float Shares:4.15B
Volume Ratio:0.90
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.354
ROE:11.64%
ROA:6.88%
PB:3.83
PE(LYR):37.66
PS:8.31

Loading ...

Movement Alert|WuXi Biologics Rises 3.4% in Regular Trading, Sustained High-Frequency Buybacks and Brazil GMP Certification Boost Confidence

Market Focus
·
Jul 03

Wuxi XDC Files HKEX Next-day Disclosure Return, Share Capital Rises by 279,500 Shares

Reuters
·
Jul 02

Wuxi Biologics (cayman) Stock Climbs 3.6% in Hong Kong

Dow Jones
·
Jul 02

Movement Alert|WuXi Biologics Rises 3.47% in Regular Trading, Sustained High-Frequency Buybacks and Brazil GMP Certification Boost Confidence

Market Focus
·
Jul 02

Wuxi Biologics Next-day Disclosure Return Flags 642,200 New Shares Issued on HKEX

Reuters
·
Jun 30

Wuxi Biologics (cayman) Stock Slips 1.9% in Hong Kong

Dow Jones
·
Jun 30

Wuxi Biologics Wins Anvisa GMP Certification for Wuxi Manufacturing Sites

Reuters
·
Jun 30

Wuxi Biologics (cayman) Stock Climbs 6.8% in Hong Kong

Dow Jones
·
Jun 29

Movement Alert|WuXi Biologics Rises 3.39% in Regular Trading, Sustained Buybacks and CXO Sector Resonance Drive Momentum

Market Focus
·
Jun 29

TOT Biopharm Shareholders Approve All AGM Resolutions by Poll

Reuters
·
Jun 26

Wuxi Biologics Says Sbti Validates New Emissions Target Matrix, Reaffirms 2050 Net-zero Goal

Reuters
·
Jun 26

Wuxi XDC Cayman Held Annual General Meeting, Shareholders Passed All Resolutions by Poll

Reuters
·
Jun 26

Wuxi XDC Appoints Yuan Fang Joint Company Secretary, Authorized Representative

Reuters
·
Jun 26

Wuxi Biologics (cayman) Stock Climbs 2.0% in Hong Kong

Dow Jones
·
Jun 25

Movement Alert|WuXi Biologics Rises 3.27% in Regular Trading, Sustained Buybacks and CXO Sector Momentum Drive Stock Higher

Market Focus
·
Jun 25

Wuxi Apptec Shares Rally Amid Sectorwide Gains After Tech Selloff, China Policy Support

Dow Jones
·
Jun 24

WuXi Biologics completes first GMP production at new Shanghai MFG17 drug substance plant

Reuters
·
Jun 24

Movement Alert|WuXi Biologics Rises 4.24% in Regular Trading, Consecutive Buybacks and Sector Momentum Lift Share Price

Market Focus
·
Jun 24

WuXi Biologics files HKEX next-day disclosure return, issues 15,000 new shares via option exercise

Reuters
·
Jun 23

Wuxi Biologics (Cayman) Stock Climbs 1.3% in Hong Kong

Dow Jones
·
Jun 23